Geospatial Mapping the Prevalence of Interstitial Lung Diseases Identified in Tertiary Care Facility and Determining the Role of Occupation in the Occurrence: A Cross-sectional Study
DOI:
https://doi.org/10.18311/jeoh/2024/43794Keywords:
GIS Mapping, Interstitial Lung Diseases, Occupation, Respiratory Illness, SmokingAbstract
Interstitial Lung Diseases (ILD) is a class of lung diseases involving diffuse parenchyma affecting alveolar, interstitial, and small airways which worsen quality of life and cause early mortality. It is important to comprehend how various occupations affect interstitial lung diseases. The purpose of this study was to determine the prevalence of ILD and the relationship between ILD and occupation. Methods and Materials: In June 2022, a retrospective analysis was carried out in a tertiary care facility. Using purposive sampling, 252 participants were chosen from the medical records. Occupation along with the duration, area of residence, and associated illness was evaluated using a questionnaire. The latitude and longitude of the areas were mapped using Q-GIS mapping and plotted on the map. Results: Among the 252 study participants, the majority of them (71%) were non-industrial workers and 29% were industrial workers. ILD affected 40% of the research patients. It was discovered that there were 86 cases of interstitial lung disease (84.3%) among industrial workers compared to 16 cases (15.7%) among non-industrial workers. This difference was statistically significant (p-value <0.05). In the Q-GIS Mapping, Clustering was found in Mysuru district, extension to Kerala, Tamil Nadu, and Andhra Pradesh. Conclusion: According to the Geospatial mapping of RespiratoryDisease cases from the past 5 years, the majority distribution is in and around Mysuru. There was a relationship between occupation and ILD was found in this study. Hence, further preventive measures are to be taken to prevent ILD in certain occupations.
Downloads
Metrics
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sruthi Sai Purnima Koduri, Nayanabai Shabadi, Anchu R. Nath
This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2024-06-03
Published 2024-08-29
References
Bourke SJ. Interstitial lung disease: Progress and problems. Postgraduate Medical Journal. Oxford Academic. 2006; 82:494–499. Available from: https:// academic.oup.com/pmj/article/82/970/494/7045325 https://doi.org/10.1136/pgmj.2006.046417
Choi WI, Dauti S, Kim HJ, Lee CW, Park SH, Park JS. Risk factors for interstitial lung disease: a 9-year nationwide population-based study. BMC Pulm Med. 2018; 18(1):96 https://doi.org/10.1186/s12890-018-0660-2
Kalchiem-Dekel, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial lung disease and pulmonary fibrosis: A practical approach for general medicine physicians with focus on the medical history. J Clin Med. 2018; 7(12):476. Available from: https://www.mdpi.com/20770383/7/12/476 https://doi.org/10.3390/jcm7120476
Rivera-Ortega P, Molina-Molina M. Molina-Molina M, Rivera-Ortega P. Interstitial lung diseases in developing countries. Ann Glob Health. 85(1):4. https://doi.org/10.5334/aogh.2414
Francesca KL, Petsonk L, Edward MD, Bruce KB, et al. Occupational interstitial lung diseases : Journal of Occupational and Environmental Medicine. 2015; 57(11):1250-1254 Available from: https://journals.lww.com/joem/fulltext/2015/11000/Occupational_Interstitial_ Lung_Diseases.16.aspx.
Corte TJ, Guler SA. Interstitial lung disease in 2020: A history of progress. Clinics in Chest Medicine. 2021; 42(2):229-39. https://doi.org/10.1016/j.ccm.2021.03.001
Hamzeh N, Mayer A. Beryllium and other metalinduced lung disease. Current Opinion in Pulmonary Medicine. 2015; 21(2):178. https://doi.org/10.1097/ MCP.0000000000000140
Antoine MH, Mlika M. Interstitial lung disease; 2019. Available from: https://europepmc.org/article/nbk/ nbk541084
Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S. Fibrosing interstitial lung diseases: Knowns and unknowns. European Respiratory Society. 2019. Available from: https://err.ersjournals.com/content/28/151/180100.short https://doi.org/10.1183/16000617.0100-2018
Karampitsakos T, Papaioannou O, Katsaras M, Sampsonas F, Tzouvelekis A. Interstitial lung diseases and the impact of gender. Clin Chest Med. 2021; 42(3):531-541. Available from: https://www.chestmed.theclinics.com/article/S02725231(21)00437-8/abstract
Dhooria S, Agarwal R, Sehgal IS, et al. Spectrum of interstitial lung diseases at a tertiary center in a developing country: A Study of 803 Subjects | PLOS ONE. 2018; 13(2). Available from: https://journals.plos.org/plosone/ article?id=10.1371/journal.pone.0191938
Six-month follow-up chest CT findings after severe covid19 pneumonia | Radiology [Internet]. Available from: https://pubs.rsna.org/doi/full/10.1148/radiol.2021203153
Fukihara J, Kondoh Y. A multifaceted look at the relationship between the two diseases. Respiratory investigation: COVID-19 and interstitial lung diseases: 2023 Sep 1;61(5):601-17. https://doi.org/10.1016/j.resinv.2023.05.007
Gifford AH, Inase N, Olson AL, Pérez ERF, Suda T. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype. European Respiratory Review. 2018; 27(150). Available from: https://err.ersjournals.com/content/27/150/180077 https://doi.org/10.1183/16000617.0077-2018